GLS and cancer: Both the decrease in oxidative decarboxylation and reductive carboxylation of Gln-derived αKG in the TCAC, as noted by reduced isotopologue fractions associated with these pathways, are metabolic events following GLS inhibition by CB-839, associated with the change in a myriad of essential metabolites involved in multiple fundamental aspects of cancer.